Abstract
Intravenous therapy for patients with a range of haematological disorders is an essential component of disease treatment. Although central venous access devices are preferred for irritant or vesicant intravenous therapies, the peripheral intravenous catheter (PIVC) has an important role, offering a simple, cost-effective way to deliver short-term, peripherally compatible treatments. Unfortunately, this important device is susceptible to failure, with more than half of all PIVCs in hospitalised patients developing complications such as occlusion, infiltration, phlebitis, dislodgement, and infections that result in device removal.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
